Navigation Links
BioSpecifics Technologies Corp. Reports Second Quarter 2008 Financial Results
Date:8/11/2008

nties which could cause actual results to differ. Please refer to our 10-KSB for specific details on our risk factors. Given these risks and uncertainties, you are cautioned not to place undue reliance on forward-looking statements. The Company's actual results could differ materially from those contained in the forward-looking statements. The Company undertakes no obligation to revise or update its forward-looking statements in order to reflect events or circumstances that may arise after the date of this release.

BIOSPECIFICS TECHNOLOGIES CORP.

Consolidated Balance Sheets

Fiscal Year

Ended

As of June 30, December 31,

2008 2007

(unaudited) (audited)

Assets

Current assets:

Cash and cash equivalents $4,741,385 $68,564

Short-term investments-(1) - 975,000

Accounts receivable, net 102,180 108,809

Prepaid expenses and other current assets 101,946 73,158

Total current assets 4,945,511 1,225,531

Long-term investments-(1) 1,020,427 -

Property, plant and equipment, net 17,133 35,680

Total assets 5,983,071 1,261,211

Liabilities and Stockholders' Deficit

Current liabilities:

Accounts payable and accrued expenses 719,623 873,460

Accrued third-party development expenses 2,272,969 2,272,969

Accrued tax liability 453,553
'/>"/>

SOURCE BioSpecifics Technologies Corp.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6

Related biology technology :

1. BioSpecifics Technologies Corp. Announces Additional Sales of Stock in Private Placement Offering
2. BioSpecifics Technologies Corp. Announces Sale of Stock in Private Placement Offering
3. BioSpecifics Technologies Corp. Announces Repayment of Outstanding Loan
4. BioSpecifics Technologies Corp. Announces Sale of Stock in Private Placement Offering
5. BioSpecifics to Present at the 9th Annual Healthcare Conference of Acumen Bio Fin Rodman Renshaw LLC
6. Mark C. Mirken Named New CEO and Chairman of the Board of Millennium Biotechnologies, Inc.
7. ImmunoVaccine Technologies Broadens Its Patent Protection to Japan
8. Neurobiological Technologies Reports Receipt of $2.1 Million Royalty Payment for Quarterly Sales of Memantine
9. MaxWell Biocorporation, LLC, and International Medical Information Technologies, Inc., Announce Partnership
10. Senesco Technologies Announces Successful Completion of First Milestone Related to Agreement with Bayer CropScience
11. [video] Edward Spink, CEO of TurboSonic Technologies, Inc. Discusses Contract With Biofuel Producer in Exclusive Interview on WallSt.nets 3-Minute Press Show
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... Sunnyvale, CA (PRWEB) May 21, 2013 ... is an 8-week training program starting on June ... to help clinical trial professionals reach the next step ... at Dentons Offices in Palo Alto, and streamed online. ... author of award-winning papers, Clinovo's new “CDISC Standards: Theory ...
(Date:5/20/2013)... May 21, 2013 Grace Century ... in “game-changing” life science and health related private equity ... to its International Project Team. Dergham's expertise in finance ... multi-cultural depth to Grace Century as it continues to ... , Ms. Dergham holds both an under graduate degree ...
(Date:5/20/2013)...  MiMedx Group, Inc. (NASDAQ: MDXG ), ... regenerative biomaterials and bioimplants processed from human amniotic membrane, ... of credit with Bank of America.  The revolving line ... accounts receivable and inventory, allows MiMedx to borrow up ... will be used for general corporate purposes. ...
(Date:5/20/2013)... 2013  (PSHR) Pacific Shore Holdings, Inc. a ... a broad range of product categories lines, today ... firm, BlueWater Advisory Group, to provide strategic counsel ... and to direct the company,s outreach and investor ... Matthew Mills , Pacific Shore Holdings, ...
Breaking Biology Technology:Clinovo Launches TechTrainings on CDISC Standards 2Dalia Dergham Joins Grace Century FZ LLC International Project Team 2Pacific Shore Holdings Retains Investor Relations Firm 2
... manufactured by using printing techniques. Imagine solar power sources ... power source. , Such advances are ... find ways of more effectively harnessing solar power and ... work is now drawing support from two international corporations. ...
... Fox Foundation for Parkinson,s Research seeks applications from industry ... (TDI). The Foundation also announced that, going forward, TDI ... a year, with up to $2.5 million in funding ... the fall.First launched in 2006, TDI is designed exclusively ...
... -- DOR BioPharma, Inc. (OTC Bulletin Board: DORB) ... Brian L. Hamilton, MD, PhD, as Senior Vice President and ... both the global development of topically active steroids as well ... and distinguished career of more than 25 years in both ...
Cached Biology Technology:Quantum dots and nanomaterials: Ingredients for better lighting and more reliable power 2Quantum dots and nanomaterials: Ingredients for better lighting and more reliable power 3Quantum dots and nanomaterials: Ingredients for better lighting and more reliable power 4Quantum dots and nanomaterials: Ingredients for better lighting and more reliable power 5Michael J. Fox Foundation Commits Up To $5 Million for Pre-Clinical Drug Development Under Industry-Exclusive Therapeutics Development Initiative 2DOR BioPharma Appoints Brian L. Hamilton, MD, PhD as Chief Medical Officer 2DOR BioPharma Appoints Brian L. Hamilton, MD, PhD as Chief Medical Officer 3DOR BioPharma Appoints Brian L. Hamilton, MD, PhD as Chief Medical Officer 4DOR BioPharma Appoints Brian L. Hamilton, MD, PhD as Chief Medical Officer 5
(Date:5/21/2013)... (ACS), the world,s largest scientific society, invites news ... Exposition, September 8-12, 2013, in Indianapolis, Ind. It ... and at area hotels. , With more than ... horizons from astronomy to zoology ― the ... a rich assortment of spot news and feature ...
(Date:5/21/2013)... -- Royal Philips Electronics (NYSE: PHG, AEX: PHIA) today ... with Philips, industry leading Live 3D TEE, now offers ... available Live 3D TEE and ICE will be shown ... official meeting for the European Association of Percutaneous Cardiovascular ... in 2012, Philips CX50 xMATRIX has been the only ...
(Date:5/20/2013)... N.Y. Little is known about the effect of ... study from Cornell University finds that increasing the amount ... reduces the probability of obesity. , The study represents ... of PE on youth obesity, and is forthcoming in ... early, online version of the study can be viewed ...
Breaking Biology News(10 mins):Philips CX50 xMATRIX now offers world-class interventional and diagnostic features on single portable system 2Gym class reduces probability of obesity, study finds for first time 2
... a new form of unregulated whaling has emerged along ... commercial sale of whales killed as fisheries "bycatch" is ... species. Scott Baker, associate director of the Marine ... of whale-meat products sold in Japanese markets suggests that ...
... / ST. PAUL (June 23, 2009) University of Minnesota Medical ... commonly prescribed drug may work to treat those infected by a ... The Schistosomasis parasite infects ... in more than 70 countries, where people become infected simply by ...
... the biologists who described the underlying causes of aging will ... symposium at the upcoming World Congress of Gerontology and ... France. The presentation, titled "Ageing Is no Longer an ... Foundation and co-sponsored by The Gerontological Society of ...
Cached Biology News:'Bycatch' whaling a growing threat to coastal whales 2U of M study finds new insight on therapy for a devastating parasitic disease 2Researchers to reveal aging's origins on global stage 2
... Service, We deliversoluble protein or No ... yields the best soluble protein results , ... clone submitted , Powerful results on your ... Solubility Optimization Service (SOS) uses proprietary tools ...
... The Rapid-Screen cDNA Library Panels were designed ... three sets of PCRs to identify the ... is performed in a 96-well "Master Plate," ... 5,000 clones. Having identified the positive well(s) ...
... The ProteinChip beta-amyloid Multipeptide Kit, designed ... makes detecting a variety of amyloid ... ever before. - Clinical neuroscience proteomics ... drug treatment - Correlate beta-amyloid peptide ...
Formula variant: With the macro- and micronutrients as described by Lloyd and McCown (1981). Preparation Quantity Equivalency: Formulated to contain 2.3 grams of powder per liter of medium. Physical ...
Biology Products: